These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11786316)

  • 21. Neurotensin-deficient mice have deficits in prepulse inhibition: restoration by clozapine but not haloperidol, olanzapine, or quetiapine.
    Kinkead B; Dobner PR; Egnatashvili V; Murray T; Deitemeyer N; Nemeroff CB
    J Pharmacol Exp Ther; 2005 Oct; 315(1):256-64. PubMed ID: 15987829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
    Richelson E; Boules M; Fredrickson P
    Life Sci; 2003 Jun; 73(6):679-90. PubMed ID: 12801589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antipsychotic-like effects of a neurotensin receptor type 1 agonist.
    Vadnie CA; Ayers-Ringler J; Oliveros A; Abulseoud OA; Choi S; Hitschfeld MJ; Choi DS
    Behav Brain Res; 2016 May; 305():8-17. PubMed ID: 26909848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotensin: perchance an endogenous neuroleptic?
    Nemeroff CB
    Biol Psychiatry; 1980 Apr; 15(2):283-302. PubMed ID: 6106513
    [No Abstract]   [Full Text] [Related]  

  • 25. Interactions of neurotensin with brain dopamine systems.
    Nemeroff CB; Hernandez DE; Luttinger D; Kalivas PW; Prange AJ
    Ann N Y Acad Sci; 1982; 400():330-44. PubMed ID: 6132577
    [No Abstract]   [Full Text] [Related]  

  • 26. A systemically administered neurotensin agonist blocks disruption of prepulse inhibition produced by a serotonin-2A agonist.
    Feifel D; Melendez G; Shilling PD
    Neuropsychopharmacology; 2003 Apr; 28(4):651-3. PubMed ID: 12655309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological specificity of the increase in neurotensin concentrations after antipsychotic drug treatment.
    Myers B; Levant B; Bissette G; Nemeroff CB
    Brain Res; 1992 Mar; 575(2):325-8. PubMed ID: 1349254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions of neurotensin with dopamine-containing neurons in the central nervous system.
    Ervin GN; Nemeroff CB
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S53-69. PubMed ID: 3074341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
    Shilling PD; Richelson E; Feifel D
    Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neurotensin, dopamine and mode of action of neuroleptics].
    Tassin JP
    Encephale; 1989; 15(5):465-70. PubMed ID: 2574102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do neuropeptide systems mediate some of the effects of antipsychotic drugs?
    Bissette G; Nemeroff CB
    Prog Clin Biol Res; 1985; 192():349-53. PubMed ID: 2867552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
    Hadden MK; Orwig KS; Kokko KP; Mazella J; Dix TA
    Neuropharmacology; 2005 Dec; 49(8):1149-59. PubMed ID: 16095636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotensin receptor agonists and antagonists for schizophrenia.
    Robertson VB; Wilson MS
    Am J Psychiatry; 2005 Mar; 162(3):634; author reply 635. PubMed ID: 15741502
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioactive analogs of neurotensin: focus on CNS effects.
    Boules M; Fredrickson P; Richelson E
    Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of haloperidol and risperidone on neurotensin levels in brain regions and neurotensin efflux in the ventral striatum of the rat.
    Gruber SH; Nomikos GG; Mathé AA
    Neuropsychopharmacology; 2002 May; 26(5):595-604. PubMed ID: 11927184
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The electrophysiological actions of neurotensin in the central nervous system.
    Stowe ZN; Nemeroff CB
    Life Sci; 1991; 49(14):987-1002. PubMed ID: 1890928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated administration of the neurotensin analogue NT69L induces tolerance to its suppressant effect on conditioned avoidance behaviour.
    Hertel P; Olsen CK; Arnt J
    Eur J Pharmacol; 2002 Mar; 439(1-3):107-11. PubMed ID: 11937099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The quetiapine active metabolite N-desalkylquetiapine and the neurotensin NTS₁ receptor agonist PD149163 exhibit antidepressant-like effects on operant responding in male rats.
    Hillhouse TM; Shankland Z; Matazel KS; Keiser AA; Prus AJ
    Exp Clin Psychopharmacol; 2014 Dec; 22(6):548-56. PubMed ID: 25285844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of acute and subchronic administration of typical and atypical antipsychotic drugs on the neurotensin system of the rat brain.
    Kinkead B; Shahid S; Owens MJ; Nemeroff CB
    J Pharmacol Exp Ther; 2000 Oct; 295(1):67-73. PubMed ID: 10991962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist.
    Sarhan S; Hitchcock JM; Grauffel CA; Wettstein JG
    Peptides; 1997; 18(8):1223-7. PubMed ID: 9396065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.